Intensity Therapeutics Selected to Present at BioCentury Future Leaders Conference

Intensity Therapeutics Selected to Present at BioCentury Future Leaders Conference

WESTPORT, Conn.–(Business Wire)–Intensity Therapeutics, Inc., a privately held biotechnology company developing proprietary immune cell activating anticancer drug products, announced that the Company has been selected to present at the 23rd annual …

(Visited 2 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.